| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K02251932 |
| PharmacoGx | BRD-K02251932 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C19orf70 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | TMEM160 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | MEGF8 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | GTSF1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | PRMT2 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | SLC38A1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | POM121 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | ZNF644 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | PTPN18 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | FAIM | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
